Free tool
FAERS Monitor: Actigall
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019594 or its brand name (Actigall, Ursodiol). Reports on generic versions are filed under their own applications.
Reports
19,985
Serious
15,684
78% of reports
Hospitalization
8,980
Death reported
2,483
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use1,828
- pruritus1,282
- diarrhoea1,130
- fatigue1,095
- nausea1,003
- drug ineffective959
- pyrexia847
- pneumonia710
- death705
- vomiting661
- headache611
- dyspnoea569
- abdominal pain533
- asthenia502
- dizziness485
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 35 |
| 2005 | 137 |
| 2006 | 66 |
| 2007 | 113 |
| 2008 | 175 |
| 2009 | 173 |
| 2010 | 229 |
| 2011 | 367 |
| 2012 | 387 |
| 2013 | 214 |
| 2014 | 274 |
| 2015 | 417 |
| 2016 | 578 |
| 2017 | 888 |
| 2018 | 1,386 |
| 2019 | 1,255 |
| 2020 | 1,321 |
| 2021 | 1,577 |
| 2022 | 2,196 |
| 2023 | 2,009 |
| 2024 | 2,075 |
| 2025 | 2,360 |
| 2026 | 1,753 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,034,174 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| pruritusSignal | 1,282 | 3.5 | 3.3 | 2,345 |
| pyrexiaSignal | 847 | 2.6 | 2.4 | 830 |
| abdominal painSignal | 533 | 2.4 | 2.2 | 444 |
| pneumoniaSignal | 710 | 2.3 | 2.1 | 534 |
| off label useSignal | 1,828 | 2.2 | 2.1 | 1,244 |
| diarrhoea | 1,130 | 1.8 | 1.7 | 449 |
| fatigue | 1,095 | 1.5 | 1.4 | 177 |
| vomiting | 661 | 1.5 | 1.4 | 105 |
| asthenia | 502 | 1.4 | 1.3 | 59 |
| nausea | 1,003 | 1.3 | 1.3 | 87 |
| dyspnoea | 569 | 1.1 | 1.0 | 2 |
| headache | 611 | 1.0 | 0.9 | 0 |
| dizziness | 485 | 1.0 | 0.9 | 0 |
| death | 705 | 0.9 | 0.8 | 16 |
| drug ineffective | 959 | 0.8 | 0.7 | 73 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.